GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Liabilities-to-Assets

Biovica International AB (OSTO:BIOVIC B) Liabilities-to-Assets : 0.34 (As of Apr. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Biovica International AB's Total Liabilities for the quarter that ended in Apr. 2025 was kr21.74 Mil. Biovica International AB's Total Assets for the quarter that ended in Apr. 2025 was kr64.95 Mil. Therefore, Biovica International AB's Liabilities-to-Assets Ratio for the quarter that ended in Apr. 2025 was 0.34.


Biovica International AB Liabilities-to-Assets Historical Data

The historical data trend for Biovica International AB's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Liabilities-to-Assets Chart

Biovica International AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.18 0.20 0.27 0.34

Biovica International AB Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.22 0.20 0.26 0.34

Competitive Comparison of Biovica International AB's Liabilities-to-Assets

For the Biotechnology subindustry, Biovica International AB's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Liabilities-to-Assets falls into.


;
;

Biovica International AB Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Biovica International AB's Liabilities-to-Assets Ratio for the fiscal year that ended in Apr. 2025 is calculated as:

Liabilities-to-Assets (A: Apr. 2025 )=Total Liabilities/Total Assets
=21.743/64.949
=0.33

Biovica International AB's Liabilities-to-Assets Ratio for the quarter that ended in Apr. 2025 is calculated as

Liabilities-to-Assets (Q: Apr. 2025 )=Total Liabilities/Total Assets
=21.743/64.949
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Biovica International AB Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines